Kodiak Sciences Inc. (KOD)

NASDAQ

$79.19

$+50.41

(+155.83%)

Regular Market

Kodiak Sciences Inc. (KOD) Live Price Chart

Last updated: ⁦2026-09-28 15:00:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Kodiak Sciences Inc. (KOD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $79.20, with a market capitalization of $2.03B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.94 to $87.28. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.03B
Open	$61.71
Day's High	$171.21
Day's Low	$1.37
Previous Close	$32.35
Volume	19.96M
Average Volume	702.44K
P/E Ratio	--
52-Week High	$87.28
52-Week Low	$10.94
Dividend Yield	--
Earnings Date	--

Kodiak Sciences Inc. (KOD) Stock Price Today

Kodiak Sciences Inc. (KOD) is currently trading at $79.20 as of 2026-09-28 14:44:48, up 144.81% ($46.84) from the previous close of $32.35

During today's regular trading session, KOD has traded between $1.37 and $171.21, with a trading volume of 19.96M shares. The current price is near the lower end of today's range.

Kodiak Sciences Inc. (KOD) 7-Day Stock Price Change

Over the past seven days, Kodiak Sciences Inc. (KOD) moved from $32.85 to $79.20, representing a gain of 141.08% ($46.34).

The stock traded between $29.81 and $87.28 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.25 million shares, up versus the previous seven-day period, indicating higher trading activity.

KOD 52-Week Price Position

Position in Range: 89.4%

52W Low$10.94

52W High$87.28

KOD is currently trading at $79.20, placing it 89.4% of the way from its 52-week low of $10.94 to its 52-week high of $87.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kodiak Sciences Inc. (KOD)?

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Kodiak Sciences Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	124
Exchange	NASDAQ
Company Website	https://www.kodiak.com

How to Buy Kodiak Sciences Inc. (KOD) Stock on MEXC

Eligible investors can buy real shares of Kodiak Sciences Inc. (KOD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KOD and Place Your Order

Open the RealStocks trading page and search for KOD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kodiak Sciences Inc. (KOD) stock price today?

Kodiak Sciences Inc. (KOD) is currently trading at $ 79.20, up 144.81% ($46.84) from the previous close of $ 32.35. Intraday prices update in real time during regular trading hours.

2.Is KOD stock going up or down today?

As of 2026-09-28 14:44:48, KOD is trading at $ 79.20, up 144.81% ($46.84) from its previous close of $ 32.35. The stock has traded between $ 1.37 and $ 171.21 during today’s regular session. Past price movements do not guarantee future results.

3.What is KOD pre-market price?

As of 2026-09-28 14:44:48, KOD is trading at $ 61.96 in pre-market trading, up 91.54% ($29.61) from the previous close of $ 32.35. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KOD after-hours price?

As of 2026-09-28 14:44:48, KOD is trading at $ 34.60 in after-hours trading, up 6.96% ($2.25) from the regular-session close of $ 32.35. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KOD stock trading now?

KOD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KOD sit relative to its 52-week high and low?

Over the past 52 weeks, KOD has traded between a low of $ 10.94 and a high of $ 87.28. At $ 79.20, the stock is positioned 89.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kodiak Sciences Inc. in?

Kodiak Sciences Inc. (KOD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kodiak Sciences Inc.'s market capitalization and where is it listed?

Kodiak Sciences Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.03B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KOD valued in terms of P/E ratio and EPS?

KOD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.85. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kodiak Sciences Inc. pay a dividend?

Kodiak Sciences Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.